0

The treatment of postpartum depression: minimizing infant exposures

Newport DJ et al., 2002

The Journal of clinical psychiatry, 63 Suppl 7, 31-44

PMID 11995777 Source

Abstract

The first 3 postpartum months represent a high-risk period for psychiatric illnesses. This article reviews the prevalence and diagnostic criteria for postpartum illnesses, including the "maternal blues," postpartum depression, and postpartum psychosis. Pharmacologic treatment of these disorders is often complicated by a patient's desire to breast-feed, yet there are no controlled trials of antidepressant treatment during lactation. Infant exposure and limitations to monitoring infant sera are reviewed. Lastly, a model and guide for reducing fetal and infant exposures is presented.

Topics

Pregnancy > Postpartum > DepressionPregnancy > Postpartum > BreastfeedingGeneral OB/GYN > Clinical Practice > Standards
postpartum depression treatment breastfeeding, antidepressant use during lactation, infant exposure to maternal medications, psychiatric illness after childbirth, postpartum blues versus depression, postpartum psychosis pharmacotherapy, breastfeeding and psychiatric medication safety, minimizing fetal drug exposure, maternal mental health newborn period

Cite this article

Newport, D. J., Hostetter, A., Arnold, A., & Stowe, Z. N. (2002). The treatment of postpartum depression: minimizing infant exposures. *The Journal of clinical psychiatry*, *63 Suppl 7*, 31-44.

Keywords

Adult, Breast Feeding, Clinical Trials As Topic, Depression, Postpartum, Drug Monitoring, Female, Fetal Diseases, Humans, Infant, Newborn, Maternal Exposure, Maternal-Child Nursing, Maternal-Fetal Exchange, Milk, Human, Practice Guidelines As Topic, Pregnancy, Prevalence, Psychotic Disorders, Puerperal Disorders, Reproducibility of Results, Risk Factors, Terminology As Topic

Related articles